Publications

  • Increase font size
  • Decrease font size
  • Print
Normandin Beaudry

New Financial Parameters for the Quebec Prescription Drug Insurance Plan

LinkedIn

There, in black and white

NB Bulletin Vol 16 N. 11, July 2013

On July 1 each year, the Régie de l’assurance maladie du Québec adjusts the financial parameters applicable to the public prescription drug insurance plan to take into account the increase or decrease in plan costs.

The table below presents that changes that will apply to all individuals covered under the public plan, with the exception of:

  • individuals who receive prescription drugs free of charge (no premium or contribution):
    • holders of a claim slip (generally recipients of last-resort financial assistance);
    • individuals aged 65 or over receiving from 94% to 100% of the Guaranteed Income Supplement (GIC);
    • children under 18 and full-time students aged 18 to 25 who do not have a spouse and live with their parents.
  • individuals aged 65 or over receiving less than 94% of the GIC who are subject to a reduced contribution.

Upward impact on private group insurance plan costs

Because the maximum contribution remains at $992 and because prescription drug costs typically increase, insured individuals will reach the maximum contribution amount faster. After this amount has been reached, 100% of the insured individual’s drug expenses must be reimbursed. This should result in an increase, however modest, in private plan costs.

Cost control measures for private plans

According to the Régie de l’assurance maladie du Québec, the freeze in public plan parameters, other than the premium for the upcoming year, was made possible with the application of certain cost control measures.

Even though Quebec’s Act respecting prescription drug insurance includes rules to be followed for private plans, it is also possible to introduce certain cost control measures in relation to these plans. However, these measures call for a process with the insurer. You can review the summary of our approach for controlling prescription drug costs by clicking here (available in French only).
 

 

Please feel free to contact us for additional information.

514.285.1122
 
630, René-Lévesque Blvd. West, 30th floor
Montreal, Quebec, H3B 1S6